A phase II trial of FUdR in patients with advanced pancreatic cancer.
Ardalan
Bach
B
University of Miami/Sylvester Comprehensive Cancer Center, Division of Hematology/Oncology, School of Medicine, Miami, Florida 33136, USA. bardalan@med.miami.edu
Lima
Mayra
M
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D005467:Floxuridine / Q000627:therapeutic use*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D005467:Floxuridine